OPRK1 and myalgic encephalomeyelitis/chronic fatigue syndrome: Following the same line of reasoning, KOR antagonists may be useful for conditions that display poor responsivity to stimulants but may benefit from moderate potentiation of arousal, such as myalgic encephalomyelitis/chronic fatigue syndrome.